'Tall oil'-derived phytosterols reduce atherosclerosis in apoE-deficient mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 1, 1997, Pages 119-126

  Moghadasian, Mohammed H ^b   McManus, Bruce M ^b   Haydn Pritchard, P ^b   Frohlich, Jiri J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

apolipoprotein E deficient mice; atherosclerosis; cholesterol; phytosterols

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; GLYCOSAMINOGLYCAN; PHYTOSTEROL; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SINUS; ARTICLE; ATHEROMATOSIS; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOAM CELL; HYPERLIPOPROTEINEMIA TYPE 3; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; XANTHOMATOSIS;

EID: 0031034429     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.1.119     Document Type: Article

References (34)

1. Gould AL, Rossouw JE, Santanello MC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit: a new look at old data. Circulation. 1995;91:2274-2282.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) expert plan on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). JAMA. 1993;269:3015-3023.
3. Ling WH, Jones PJH. Enhanced efficacy of sitostanol-containing versus sitostanol-free phytosterol mixtures in altering lipoprotein cholesterol levels and synthesis in rats. Atherosclerosis. 1995;118:319-331.
4. Laraki L, Pelletier X, Debry G. Effects of dietary cholesterol and phytosterol overload on Wistar rat plasma lipids. Ann Nutr Metab. 1991;35:221-225.
5. Becker M, Staab D, von Bergmann K. Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol J Pediatr. 1993;122:292-296.
6. Heinemann T, Leiss O, von Bergmann K. Effects of low dose sitostanol on serum cholesterol in patients with hypercholesterolemia. Atherosclerosis. 1986;61:219-223.
7. Miettinen TA, Puska P, Glyying H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N EngI J Med. 1995;333:1308-1312.
8. Heinemann T, Axtmann G, von Bergmann X. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J din Invest. 1993;23:827-831.
9. Vahouny GV, Connor WE, Subramaniam S, Lin DS, Gallo LL. Comparative lymphatic absorption of sitosterol, stigmasterol, and fucosterol and differential inhibition of cholesterol absorption. Am J Clin Nutr. 1983;37:805-809.
10. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. Apo E-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133-140.
11. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.
12. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-471.
13. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum J. Apo E-deficient mice are a model of lipoprotein oxidation in atherogenesis: demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb. 1994;14:605-616.
14. Plump AS, Scott CJ, Breslow JL. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA. 1994;91:9607-9611.
15. van Ree JH, Gijbels MJJ, van den Broek WJAA, Hofker MH, Havekes LM. Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding. Atherosclerosis. 1995;112:237-243.
16. Tangirala RK, Casanada F, Miller E, Witztum JL, Steinberg D, Palinski W. Effects of the antioxidant N,N′-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice. Arterioscler Thromb Vasc Biol. 1995;15:1625-1630.
17. Dobiasova M, Stribma J, Sparks DL, Pritchard PH, Frohlich JJ. Cholesterol esterification rates in very low-density lipoprotein- and low-density lipoprotein-depleted plasma: relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease. Arterioscler Thromb. 1991;11:64-70.
18. Allain CC, Poon LS, Chan CS, Richmond W. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;29:470-475.
19. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476-482.
20. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987;68:231-240.
21. Pászty C, Maeda N, Verstuyft J, Rubin EM. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest. 1994;94:899-903.
22. Zhang SH, Reddick RL, Burkey B, Maeda N. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest. 1994;94:937-945.
23. van Ree JH, van den Broek WJAA, Dahlmans VEH, Groot PHE, Vidgeon-Hart M, Frants RR, Wieringa B, Havekes LM, Hofker MH. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis. 1994;111:25-37.
24. Laraki L, Pelletier X, Mourot J, Debry G. Effects of dietary phytosterols on liver lipids and lipid metabolism enzymes. Ann Nutr Metab. 1993;37:129-133.
25. Ikeda I, Tanaka K, Sugano M, Vahouny GV, Gallo LL. Inhibition of cholesterol absorption in rats by plant sterols. J Lipid Res. 1988;29:1573-1582.
26. Heinemann T, Kullak-Ublick GA, Pietruck B, von Bergmann K. Mechanisms of action of plant sterols on inhibition of cholesterol absorption: comparison of sitosterol and sitostanol. Eur J Clin Pharmacol. 1991;40:S59-S63.
27. Ikeda I, Tanaka K, Sugano M, Vahouny GV, Gallo LL. Discrimination between cholesterol and sitosterol for absorption in rats. J Lipid Res. 1988;29:1583-1591.
28. Weisweiler P, Heinemann V, Schwandt P. Serum lipoproteins and lecithin:cholesterol acyltransferase (LCAT) activity in hypercholesterolemic subjects given β-sitosterol. Int J Clin Pharmacol. 1984;22:204-206.
29. Boberg KM, Åkerlund J, Björkhem I. Effect of sitosterol on the ratelimiting enzymes in cholesterol synthesis and degradation. Lipids. 1989;24:9-12.
30. Shefer S, Hauser S, Lapar V, Mosbach EH. Regulatory effects of sterols and bile acids on hepatic 3-hydroxy-3-methylglutaryl CoA reductase and cholesterol 7α-hydroxylase in the rat. J Lipid Res. 1973;14:573-580.
31. Shefer S, Salen G, Bullock J, Nguyen LB, Ness GC, Vhao Z, Bela-marich PF, Chowdhary I, Lerner S, Batta AK, Tint GS. The effect of increased hepatic sitosterol on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol 7α-hydroxylase in the rat and sitosterolemic homozygotes. Hepatology, 1994;20:213-219.
32. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results, II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;251:365-374.
33. Aviram M, Eias K. Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation. Ann Nutr Metab. 1993;37:75-84.
34. Hayek T, Oiknine J, Brook JG, Aviram M. Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. Biochem Biophys Res Commun. 1994;201:1567-1574.